Rules-Based Medicine (RBM)

3300 Duval Road,
Austin, Texas 78759
United States,

Rules-Based Medicine (RBM) is a multiplexed biomarker testing laboratory, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform.

Rules-Based Medicine was acquired by Myriad Genetics on June 01, 2011.

Join Mergr to view all 163 acquisitions of life science companies in 2011, including 17 acquisitions by private equity firms, and 146 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Rules-Based Medicine.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.